Point72 Asset Management, L.P.

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1603466 STAMFORD, CT

Back to TAK Full portfolio

Position in TAK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,244,857

+$892,673 QoQ

Shares Held

77,658

+191.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#93

of 376 holders

Holding Since

Dec 2020

9 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $450,936,643 across 22 Drug Manufacturers - Specialty & Generic names. TAK ranks #16 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	201,159	$108,993,980
2	HLN	Haleon plc	9,264,255	$86,435,499
3	LNTH	Lantheus Holdings, Inc.	629,806	$69,870,677
4	INDV	Indivior Pharmaceuticals, Inc.	1,250,639	$51,313,718
5	KNSA	Kiniksa Pharmaceuticals International, plc	659,493	$42,174,577
6	TEVA	Teva Pharmaceutical Industries Ltd	1,059,778	$35,905,278
7	BHC	Bausch Health Companies Inc.	2,235,821	$11,022,597
8	EOLS	Evolus, Inc.	1,508,518	$10,469,114

All Filings in TAK

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,244,857	77,658	+191.9%	Shares	Defined	2026-08-14
2024-12-31	$352,184	26,600	-87.1%	Shares	Defined	2025-02-14
2024-03-31	$2,862,729	206,100	-90.3%	Shares	Defined	2024-05-15
2023-06-30	$33,391,605	2,125,500	-15.9%	Shares	Defined	2023-08-14
2023-03-31	$41,674,574	2,528,797	-9.1%	Shares	Defined	2023-05-15
2022-12-31	$43,410,120	2,782,700	+114.1%	Shares	Defined	2023-05-15
2021-09-30	$21,292,362	1,299,900	-5.6%	Shares	Defined	2021-11-15
2021-06-30	$23,174,910	1,377,000	+111.4%	Shares	Defined	2021-08-16
2020-12-31	$11,853,660	651,300	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.